Literature DB >> 862409

Acute renal failure. Community hospital experience with hemodialysis as intensive care adjunct.

W E Dandy, D G Sapir.   

Abstract

A 3-year experience with 50 acute renal failure patients managed by hemodialysis in a 417-bed community hospital is reviewed. The 58% survival rate was better than that reported in other recent series. Possible reasons for our favorable mortality experience include: (1) Hemodialysis was performed within the ICU facility by the ICU staff. Continuity of total care was thereby maintained and hemodialysis problems, such as maintenance of circulating volume, were managed in the context of continued assessment of the patient's cardiopulmonary status. (2) In contrast to previous reports, the presence of sepsis did not influence recovery rates from acute renal failure. Early administration of specific antibiotics, mainly gentamicin, rapid drainage of abdominal abscesses, and early and frequent dialysis were all utilized in spetic patients and may have contributed to their high recovery rate. (3) The use of agressive dialysis may also have lessened other uremic complications, notably gastrointestinal bleeding. Our dialysis organization and procedures are described.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 862409     DOI: 10.1097/00003246-197705000-00005

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  2 in total

1.  Survial from acute renal failure with and without multiple organ dysfunction.

Authors:  G S Routh; J D Briggs; J G Mone; I M Ledingham
Journal:  Postgrad Med J       Date:  1980-04       Impact factor: 2.401

2.  Renal replacement therapy in adult and pediatric intensive care : Recommendations by an expert panel from the French Intensive Care Society (SRLF) with the French Society of Anesthesia Intensive Care (SFAR) French Group for Pediatric Intensive Care Emergencies (GFRUP) the French Dialysis Society (SFD).

Authors:  Christophe Vinsonneau; Emma Allain-Launay; Clarisse Blayau; Michael Darmon; Damien Ducheyron; Theophile Gaillot; Patrick M Honore; Etienne Javouhey; Thierry Krummel; Annie Lahoche; Serge Letacon; Matthieu Legrand; Mehran Monchi; Christophe Ridel; René Robert; Frederique Schortgen; Bertrand Souweine; Patrick Vaillant; Lionel Velly; David Osman; Ly Van Vong
Journal:  Ann Intensive Care       Date:  2015-12-30       Impact factor: 6.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.